Understanding correct injection technique ensures optimal treatment outcomes, minimises side effects, and supports long-term adherence to these subcutaneous therapies used for type 2 diabetes and weight management
10.1016/j.bbrep.2023.101578 173
Here's a brief overview of each peptide: CJC-1295 : A modified version of growth hormone-releasing hormone (GHRH), CJC-1295 helps promote sustained release of growth hormone with a prolonged half-life
A 17% Reduction in Overall Cancer Risk A landmark study published in JAMA Oncology (Dai H et al., August 2025), drawing on data from 14 health systems encompassing approximately 20 million patients, found that adults with obesity who were prescribed GLP-1 receptor agonists had a 17% lower risk of developing cancer compared to carefully matched non-users
Retatrutide is an investigational weight loss medication and is not FDA-approved at this time
Behemoth Labz offers Melanotan 2 Nasal Spray for sale for research purposes